Trends of insulin use among US adults with type 2 diabetes: The Behavioral Risk Factor Surveillance System, 1995-2007

Journal of Diabetes and its Complications

Volumn 26, Issue 1, 2012, Pages 17-22

  Li, Chaoyang ^a   Ford, Earl S ^b   Zhao, Guixiang ^a   Tsai, James ^c   Balluz, Lina S ^a   Giles, Wayne H ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Diabetes; Insulin therapy; Prevalence; Race ethnicity; Trend

Indexed keywords

INSULIN;

ADULT; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GLYCEMIC CONTROL; HUMAN; INFORMATION PROCESSING; INSULIN TREATMENT; LINEAR REGRESSION ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; TREND STUDY;

ADULT; AGED; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DRUG UTILIZATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; SELF REPORT;

EID: 84859104018     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2011.11.005     Document Type: Article

References (44)

1. L. Aviles-Santa, J. Sinding, and P. Raskin Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 131 1999 182 188 (Pubitemid 29365000)
2. S.J. Bowlin, B.D. Morrill, A.N. Nafziger, P.L. Jenkins, C. Lewis, and T.A. Pearson Validity of cardiovascular disease risk factors assessed by telephone survey: the Behavioral Risk Factor Survey Journal of Clinical Epidemiology 46 1993 561 571 (Pubitemid 23194281)
3. J.P. Boyle, M.M. Engelgau, T.J. Thompson, M.G. Goldschmid, G.L. Beckles, and D.S. Timberlake Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitus American Journal of Epidemiology 149 1999 55 63 (Pubitemid 29028862)
4. J.B. Brown, G.A. Nichols, and A. Perry The burden of treatment failure in type 2 diabetes Diabetes Care 27 2004 1535 1540 (Pubitemid 38857422)
5. A.E. Caballero Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes Journal of Diabetes and its Complications 23 2009 143 152
6. Centers for Disease Control and Prevention Behavioral Risk Factor Surveillance System user's guide 2006 Centers for Disease Control and Prevention Atlanta, GA
7. Centers for Disease Control and Prevention National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007 2008 U.S. Department of Health and Human Services, Center for Disease Control and Prevention Atlanta, GA
8. J.S. Codogno, R.A. Fernandes, F.M. Sarti, J.I. Freitas, and H.L. Monteiro The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study BMC Public Health 11 2011 275
9. H.M. Colhoun Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 2009 1755 1765
10. C.J. Currie, C.D. Poole, and E.A. Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 2009 1766 1777
11. S.N. Davis, and S.M. Renda Psychological insulin resistance: overcoming barriers to starting insulin therapy The Diabetes Educator 32 Suppl 4 2006 146S 152S
12. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, and P.D. Reaven Glucose control and vascular complications in veterans with type 2 diabetes The New England Journal of Medicine 360 2009 129 139
13. L.E. Egede, M. Gebregziabher, K.J. Hunt, R.N. Axon, C. Echols, and G.E. Gilbert Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes Diabetes Care 34 2011 938 943
14. M.M. Engelgau, L.S. Geiss, J.B. Saaddine, J.P. Boyle, S.M. Benjamin, and E.W. Gregg The evolving diabetes burden in the United States Annals of Internal Medicine 140 2004 945 950 (Pubitemid 38685285)
15. R.A. Fernandes, and A. Zanesco Early physical activity promotes lower prevalence of chronic diseases in adulthood Hypertension Research 33 2010 926 931
16. E.S. Ford, C. Li, R.R. Little, and A.H. Mokdad Trends in A1C concentrations among U.S. adults with diagnosed diabetes from 1999 to 2004 Diabetes Care 31 2008 102 104
17. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., J.T. Bigger, and J.B. Buse Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine 358 2008 2545 2559 (Pubitemid 351831356)
18. C.S. Gobl, W. Brannath, L. Bozkurt, A. Handisurya, C. Anderwald, and A. Luger Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus Gender Medicine 7 2010 593 599
19. S.C. Gorber, M. Tremblay, D. Moher, and B. Gorber A comparison of direct vs. self-report measures for assessing height, weight and body mass index: a systematic review Obesity Reviews 8 2007 307 326 (Pubitemid 46944496)
20. G.C. Hall, A.D. McMahon, M.P. Dain, and P.D. Home A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes Diabetes Research and Clinical Practice 2011
21. L.G. Hemkens, U. Grouven, R. Bender, C. Gunster, S. Gutschmidt, and G.W. Selke Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 2009 1732 1744
22. R.R. Holman, A.J. Farmer, M.J. Davies, J.C. Levy, J.L. Darbyshire, and J.F. Keenan Three-year efficacy of complex insulin regimens in type 2 diabetes The New England Journal of Medicine 361 2009 1736 1747
23. P.L. Huang eNOS, metabolic syndrome and cardiovascular disease Trends in Endocrinology and Metabolism 20 2009 295 302
24. L.J. Ignarro, M.L. Balestrieri, and C. Napoli Nutrition, physical activity, and cardiovascular disease: an update Cardiovascular Research 73 2007 326 340 (Pubitemid 44970442)
25. J.M. Jonasson, R. Ljung, M. Talback, B. Haglund, S. Gudbjornsdottir, and G. Steineck Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 2009 1745 1754
26. L. Jovanovic Sex differences in insulin dose and postprandial glucose as BMI increases in patients with type 2 diabetes Diabetes Care 32 2009 e148
27. M. Khattab, Y.S. Khader, A. Al-Khawaldeh, and K. Ajlouni Factors associated with poor glycemic control among patients with type 2 diabetes Journal of Diabetes and its Complications 24 2010 84 89
28. C.E. Koro, S.J. Bowlin, N. Bourgeois, and D.O. Fedder Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report Diabetes Care 27 2004 17 20 (Pubitemid 38196703)
29. N. Lammi, O. Taskinen, E. Moltchanova, I.L. Notkola, J.G. Eriksson, and J. Tuomilehto A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996 Diabetologia 50 2007 1393 1400 (Pubitemid 46879019)
30. D.S. Lasserson, P. Glasziou, R. Perera, R.R. Holman, and A.J. Farmer Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses Diabetologia 52 2009 1990 2000
31. C. Li, E.S. Ford, T.W. Strine, and A.H. Mokdad Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system Diabetes Care 31 2008 105 107
32. C. Makine, C. Karsidag, P. Kadioglu, H. Ilkova, K. Karsidag, and S.E. Skovlund Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research Consortium Diabetic Medicine 26 2009 28 33
33. D.G. Marrero Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus Clinical Cornerstone 8 2007 33 40
34. A.H. Mokdad, E.S. Ford, B.A. Bowman, D.E. Nelson, M.M. Engelgau, and F. Vinicor Diabetes trends in the U.S.: 1990-1998 Diabetes Care 23 2000 1278 1283
35. D.M. Nathan, J.B. Buse, M.B. Davidson, E. Ferrannini, R.R. Holman, and R. Sherwin Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 2009 193 203
36. S.A. Oliveria, L.A. Menditto, Y.M. Ulcickas, Y.H. Koo, K.E. Wells, and B.D. McCarthy Barriers to the initiation of, and persistence with, insulin therap Current Medical Research and Opinion 23 2007 3105 3112
37. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, and M. Woodward Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes The New England Journal of Medicine 358 2008 2560 2572 (Pubitemid 351831357)
38. J.N. Pearcy, and K.G. Keppel A summary measure of health disparity Public Health Reports 117 2002 273 280 (Pubitemid 35351236)
39. M. Peyrot, R.R. Rubin, T. Lauritzen, S.E. Skovlund, F.J. Snoek, and D.R. Matthews Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study Diabetes Care 28 2005 2673 2679 (Pubitemid 43951158)
40. W.H. Polonsky, L. Fisher, S. Guzman, L. Villa-Caballero, and S.V. Edelman Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem Diabetes Care 28 2005 2543 2545 (Pubitemid 41384310)
41. I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, and C.A. Cull Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412 (Pubitemid 30609442)
42. S.M. Strowig, M.L. viles-Santa, and P. Raskin Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes Diabetes Care 25 2002 1691 1698 (Pubitemid 41071072)
43. M. Stumvoll, B.J. Goldstein, and T.W. van Haeften Type 2 diabetes: principles of pathogenesis and therapy Lancet 365 2005 1333 1346
44. World Health Organization Study Group Prevention of diabetes. vol 13 1994 World Health Organization Geneva